Post hoc analysis of OVHIPEC-1 (237 of 245 with baseline CT) in stage III ovarian cancer: cardiophrenic lymph nodes 5-10 mm (44%) did not affect overall survival (HR 0.98) or HIPEC benefit (interaction P=0.28).
Secondary analysisn = 237
Schreuder Goedheijt et al. Influence of cardiophrenic lymph nodes on survival in patients receiving hyperthermic intraperitoneal chemotherapy for ovarian cancer in the OVHIPEC-1 trial